APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Detection Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tumor Detection Services Market Outlook and Growth Opportunities 2026

5 June 2026200 pages

Choose your research edition.

Industry ResearchTumor Detection Services Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Detection Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Tumor Detection Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Detection Services Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Detection Services Market Analysis and Forecast 2026-2032250 pages · $4,950 USD

Market perspective

The global Tumor Detection Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tumor Detection Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tumor Detection Services market include Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta and Bio-Techne, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Tumor Detection Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Detection Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Detection Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Tumor Detection Services market.

Tumor Detection Services Segment by Company

Nonacus

Natera

Penn Medicine

Amadix

Oncologica

Rarecells

GRAIL

Elypta

Bio-Techne

iCAD

Dxcover

Caris Life Sciences

Novocure

Circulogene

Guardant Health

Veracyte

Haystack Oncology

Foundation Medicine

Tumor Detection Services Segment by Type

Non-Invasive Examination

Invasive Examination

Tumor Detection Services Segment by Application

Adults

Children

Tumor Detection Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tumor Detection Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Tumor Detection Services key companies, revenue, market share, and recent developments.

3. To split the Tumor Detection Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Tumor Detection Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tumor Detection Services significant trends, drivers, influence factors in global and regions.

6. To analyze Tumor Detection Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Detection Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Detection Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Detection Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Detection Services industry.

Chapter 3: Detailed analysis of Tumor Detection Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Tumor Detection Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Tumor Detection Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tumor Detection Services Industry Trends Table 2. Tumor Detection Services Industry Drivers Table 3. Tumor Detection Services Industry Opportunities and Challenges Table 4. Tumor Detection Services Industry Restraints Table 5. Global Tumor Detection Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tumor Detection Services Revenue Share by Company (2021-2026) Table 7. Global Tumor Detection Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Tumor Detection Services Key Company Manufacturing Base & Headquarters Table 9. Global Tumor Detection Services Company, Product Type & Application Table 10. Global Tumor Detection Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Tumor Detection Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Non-Invasive Examination Table 15. Significant Companies of Invasive Examination Table 16. Global Tumor Detection Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Tumor Detection Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Tumor Detection Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Tumor Detection Services Sales Value Share by Type (2021-2026) Table 20. Global Tumor Detection Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Adults Table 22. Significant Companies of Children Table 23. Global Tumor Detection Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Tumor Detection Services Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Tumor Detection Services Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Tumor Detection Services Sales Value Share by Application (2021-2026) Table 27. Global Tumor Detection Services Sales Value Share by Application (2027-2032) Table 28. Global Tumor Detection Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Tumor Detection Services Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Tumor Detection Services Sales Value Share by Region (2021-2026) Table 31. Global Tumor Detection Services Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Tumor Detection Services Sales Value Share by Region (2027-2032) Table 33. Global Tumor Detection Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Tumor Detection Services Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Tumor Detection Services Sales Value Market Share by Country (2021-2026) Table 36. Global Tumor Detection Services Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Tumor Detection Services Sales Value Market Share by Country (2027-2032) Table 38. Nonacus Company Information Table 39. Nonacus Business Overview Table 40. Nonacus Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Nonacus Tumor Detection Services Product Portfolio Table 42. Nonacus Recent Development Table 43. Natera Company Information Table 44. Natera Business Overview Table 45. Natera Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Natera Tumor Detection Services Product Portfolio Table 47. Natera Recent Development Table 48. Penn Medicine Company Information Table 49. Penn Medicine Business Overview Table 50. Penn Medicine Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Penn Medicine Tumor Detection Services Product Portfolio Table 52. Penn Medicine Recent Development Table 53. Amadix Company Information Table 54. Amadix Business Overview Table 55. Amadix Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Amadix Tumor Detection Services Product Portfolio Table 57. Amadix Recent Development Table 58. Oncologica Company Information Table 59. Oncologica Business Overview Table 60. Oncologica Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Oncologica Tumor Detection Services Product Portfolio Table 62. Oncologica Recent Development Table 63. Rarecells Company Information Table 64. Rarecells Business Overview Table 65. Rarecells Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Rarecells Tumor Detection Services Product Portfolio Table 67. Rarecells Recent Development Table 68. GRAIL Company Information Table 69. GRAIL Business Overview Table 70. GRAIL Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GRAIL Tumor Detection Services Product Portfolio Table 72. GRAIL Recent Development Table 73. Elypta Company Information Table 74. Elypta Business Overview Table 75. Elypta Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Elypta Tumor Detection Services Product Portfolio Table 77. Elypta Recent Development Table 78. Bio-Techne Company Information Table 79. Bio-Techne Business Overview Table 80. Bio-Techne Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bio-Techne Tumor Detection Services Product Portfolio Table 82. Bio-Techne Recent Development Table 83. iCAD Company Information Table 84. iCAD Business Overview Table 85. iCAD Tumor Detection Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. iCAD Tumor Detection Services Product Portfolio Table 87. iCAD Recent Development Table 88. Dxcover Company Information Table 89. Dxcover Business Overview Table 90. Dxcover Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Dxcover Tumor Detection Services Product Portfolio Table 92. Dxcover Recent Development Table 93. Caris Life Sciences Company Information Table 94. Caris Life Sciences Business Overview Table 95. Caris Life Sciences Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Caris Life Sciences Tumor Detection Services Product Portfolio Table 97. Caris Life Sciences Recent Development Table 98. Novocure Company Information Table 99. Novocure Business Overview Table 100. Novocure Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Novocure Tumor Detection Services Product Portfolio Table 102. Novocure Recent Development Table 103. Circulogene Company Information Table 104. Circulogene Business Overview Table 105. Circulogene Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Circulogene Tumor Detection Services Product Portfolio Table 107. Circulogene Recent Development Table 108. Guardant Health Company Information Table 109. Guardant Health Business Overview Table 110. Guardant Health Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Guardant Health Tumor Detection Services Product Portfolio Table 112. Guardant Health Recent Development Table 113. Veracyte Company Information Table 114. Veracyte Business Overview Table 115. Veracyte Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Veracyte Tumor Detection Services Product Portfolio Table 117. Veracyte Recent Development Table 118. Haystack Oncology Company Information Table 119. Haystack Oncology Business Overview Table 120. Haystack Oncology Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Haystack Oncology Tumor Detection Services Product Portfolio Table 122. Haystack Oncology Recent Development Table 123. Foundation Medicine Company Information Table 124. Foundation Medicine Business Overview Table 125. Foundation Medicine Tumor Detection Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Foundation Medicine Tumor Detection Services Product Portfolio Table 127. Foundation Medicine Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Tumor Detection Services Product Image Figure 2. Global Tumor Detection Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Detection Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Tumor Detection Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Non-Invasive Examination Image Figure 8. Invasive Examination Image Figure 9. Global Tumor Detection Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Tumor Detection Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Tumor Detection Services Sales Value Share by Type (2021-2032) Figure 12. Adults Image Figure 13. Children Image Figure 14. Global Tumor Detection Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Tumor Detection Services Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Tumor Detection Services Sales Value Share by Application (2021-2032) Figure 17. Global Tumor Detection Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Tumor Detection Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Tumor Detection Services Sales Value (2021-2032) & (US$ Million) Figure 20. North America Tumor Detection Services Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Tumor Detection Services Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Tumor Detection Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Tumor Detection Services Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Tumor Detection Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Tumor Detection Services Sales Value (2021-2032) & (US$ Million) Figure 26. South America Tumor Detection Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Tumor Detection Services Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Tumor Detection Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Tumor Detection Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Tumor Detection Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Tumor Detection Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Non-Invasive Examination
  • Invasive Examination
Applications
  • Adults
  • Children
Companies covered
  • Nonacus
  • Natera
  • Penn Medicine
  • Amadix
  • Oncologica
  • Rarecells
  • GRAIL
  • Elypta
  • Bio-Techne
  • iCAD
  • Dxcover
  • Caris Life Sciences
  • Novocure
  • Circulogene
  • Guardant Health
  • Veracyte
  • Haystack Oncology
  • Foundation Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tumor Detection Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tumor Detection Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Tumor Detection Services Market Dynamics
  1. 2.1 Tumor Detection Services Industry Trends
  2. 2.2 Tumor Detection Services Industry Drivers
  3. 2.3 Tumor Detection Services Industry Opportunities and Challenges
  4. 2.4 Tumor Detection Services Industry Restraints
3 Tumor Detection Services Market by Company
  1. 3.1 Global Tumor Detection Services Company Revenue Ranking in 2025
  2. 3.2 Global Tumor Detection Services Revenue by Company (2021-2026)
  3. 3.3 Global Tumor Detection Services Company Ranking (2024-2026)
  4. 3.4 Global Tumor Detection Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Tumor Detection Services Company Product Type and Application
  6. 3.6 Global Tumor Detection Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Tumor Detection Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Tumor Detection Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Tumor Detection Services Market by Type
  1. 4.1 Tumor Detection Services Type Introduction
  2. 4.1.1 Non-Invasive Examination
  3. 4.1.2 Invasive Examination
  4. 4.2 Global Tumor Detection Services Sales Value by Type
  5. 4.2.1 Global Tumor Detection Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tumor Detection Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Tumor Detection Services Sales Value Share by Type (2021-2032)
5 Tumor Detection Services Market by Application
  1. 5.1 Tumor Detection Services Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Tumor Detection Services Sales Value by Application
  5. 5.2.1 Global Tumor Detection Services Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Tumor Detection Services Sales Value by Application (2021-2032)
  7. 5.2.3 Global Tumor Detection Services Sales Value Share by Application (2021-2032)
6 Tumor Detection Services Regional Value Analysis
  1. 6.1 Global Tumor Detection Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tumor Detection Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Tumor Detection Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Tumor Detection Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tumor Detection Services Sales Value (2021-2032)
  7. 6.3.2 North America Tumor Detection Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Tumor Detection Services Sales Value (2021-2032)
  10. 6.4.2 Europe Tumor Detection Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Tumor Detection Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Tumor Detection Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Tumor Detection Services Sales Value (2021-2032)
  16. 6.6.2 South America Tumor Detection Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Tumor Detection Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Tumor Detection Services Sales Value Share by Country, 2025 VS 2032
7 Tumor Detection Services Country-level Value Analysis
  1. 7.1 Global Tumor Detection Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tumor Detection Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Tumor Detection Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Tumor Detection Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Tumor Detection Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Tumor Detection Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Tumor Detection Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Tumor Detection Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Tumor Detection Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Tumor Detection Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Tumor Detection Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Tumor Detection Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Tumor Detection Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Tumor Detection Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Tumor Detection Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Tumor Detection Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Tumor Detection Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Tumor Detection Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Tumor Detection Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Tumor Detection Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Tumor Detection Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Tumor Detection Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Tumor Detection Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Tumor Detection Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Tumor Detection Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Tumor Detection Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Tumor Detection Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Tumor Detection Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Tumor Detection Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Tumor Detection Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Tumor Detection Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Tumor Detection Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Tumor Detection Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Tumor Detection Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Nonacus
  2. 8.1.1 Nonacus Company Information
  3. 8.1.2 Nonacus Business Overview
  4. 8.1.3 Nonacus Tumor Detection Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nonacus Tumor Detection Services Product Portfolio
  6. 8.1.5 Nonacus Recent Developments
  7. 8.2 Natera
  8. 8.2.1 Natera Company Information
  9. 8.2.2 Natera Business Overview
  10. 8.2.3 Natera Tumor Detection Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Natera Tumor Detection Services Product Portfolio
  12. 8.2.5 Natera Recent Developments
  13. 8.3 Penn Medicine
  14. 8.3.1 Penn Medicine Company Information
  15. 8.3.2 Penn Medicine Business Overview
  16. 8.3.3 Penn Medicine Tumor Detection Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Penn Medicine Tumor Detection Services Product Portfolio
  18. 8.3.5 Penn Medicine Recent Developments
  19. 8.4 Amadix
  20. 8.4.1 Amadix Company Information
  21. 8.4.2 Amadix Business Overview
  22. 8.4.3 Amadix Tumor Detection Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amadix Tumor Detection Services Product Portfolio
  24. 8.4.5 Amadix Recent Developments
  25. 8.5 Oncologica
  26. 8.5.1 Oncologica Company Information
  27. 8.5.2 Oncologica Business Overview
  28. 8.5.3 Oncologica Tumor Detection Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Oncologica Tumor Detection Services Product Portfolio
  30. 8.5.5 Oncologica Recent Developments
  31. 8.6 Rarecells
  32. 8.6.1 Rarecells Company Information
  33. 8.6.2 Rarecells Business Overview
  34. 8.6.3 Rarecells Tumor Detection Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rarecells Tumor Detection Services Product Portfolio
  36. 8.6.5 Rarecells Recent Developments
  37. 8.7 GRAIL
  38. 8.7.1 GRAIL Company Information
  39. 8.7.2 GRAIL Business Overview
  40. 8.7.3 GRAIL Tumor Detection Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GRAIL Tumor Detection Services Product Portfolio
  42. 8.7.5 GRAIL Recent Developments
  43. 8.8 Elypta
  44. 8.8.1 Elypta Company Information
  45. 8.8.2 Elypta Business Overview
  46. 8.8.3 Elypta Tumor Detection Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Elypta Tumor Detection Services Product Portfolio
  48. 8.8.5 Elypta Recent Developments
  49. 8.9 Bio-Techne
  50. 8.9.1 Bio-Techne Company Information
  51. 8.9.2 Bio-Techne Business Overview
  52. 8.9.3 Bio-Techne Tumor Detection Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bio-Techne Tumor Detection Services Product Portfolio
  54. 8.9.5 Bio-Techne Recent Developments
  55. 8.10 iCAD
  56. 8.10.1 iCAD Company Information
  57. 8.10.2 iCAD Business Overview
  58. 8.10.3 iCAD Tumor Detection Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 iCAD Tumor Detection Services Product Portfolio
  60. 8.10.5 iCAD Recent Developments
  61. 8.11 Dxcover
  62. 8.11.1 Dxcover Company Information
  63. 8.11.2 Dxcover Business Overview
  64. 8.11.3 Dxcover Tumor Detection Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dxcover Tumor Detection Services Product Portfolio
  66. 8.11.5 Dxcover Recent Developments
  67. 8.12 Caris Life Sciences
  68. 8.12.1 Caris Life Sciences Company Information
  69. 8.12.2 Caris Life Sciences Business Overview
  70. 8.12.3 Caris Life Sciences Tumor Detection Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Caris Life Sciences Tumor Detection Services Product Portfolio
  72. 8.12.5 Caris Life Sciences Recent Developments
  73. 8.13 Novocure
  74. 8.13.1 Novocure Company Information
  75. 8.13.2 Novocure Business Overview
  76. 8.13.3 Novocure Tumor Detection Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Novocure Tumor Detection Services Product Portfolio
  78. 8.13.5 Novocure Recent Developments
  79. 8.14 Circulogene
  80. 8.14.1 Circulogene Company Information
  81. 8.14.2 Circulogene Business Overview
  82. 8.14.3 Circulogene Tumor Detection Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Circulogene Tumor Detection Services Product Portfolio
  84. 8.14.5 Circulogene Recent Developments
  85. 8.15 Guardant Health
  86. 8.15.1 Guardant Health Company Information
  87. 8.15.2 Guardant Health Business Overview
  88. 8.15.3 Guardant Health Tumor Detection Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guardant Health Tumor Detection Services Product Portfolio
  90. 8.15.5 Guardant Health Recent Developments
  91. 8.16 Veracyte
  92. 8.16.1 Veracyte Company Information
  93. 8.16.2 Veracyte Business Overview
  94. 8.16.3 Veracyte Tumor Detection Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Veracyte Tumor Detection Services Product Portfolio
  96. 8.16.5 Veracyte Recent Developments
  97. 8.17 Haystack Oncology
  98. 8.17.1 Haystack Oncology Company Information
  99. 8.17.2 Haystack Oncology Business Overview
  100. 8.17.3 Haystack Oncology Tumor Detection Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Haystack Oncology Tumor Detection Services Product Portfolio
  102. 8.17.5 Haystack Oncology Recent Developments
  103. 8.18 Foundation Medicine
  104. 8.18.1 Foundation Medicine Company Information
  105. 8.18.2 Foundation Medicine Business Overview
  106. 8.18.3 Foundation Medicine Tumor Detection Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Foundation Medicine Tumor Detection Services Product Portfolio
  108. 8.18.5 Foundation Medicine Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst